Management of inflammatory bowel disease in the elderly: A review

Dig Liver Dis. 2023 Aug;55(8):1001-1009. doi: 10.1016/j.dld.2022.12.024. Epub 2023 Jan 19.

Abstract

The burden of Inflammatory Bowel Disease (IBD) is increasing worldwide, with a particular increase in the prevalence in the elderly population, due to the ageing of young-onset IBD as well as to the increasing incidence in elderly patients. Elderly IBD patients present specific challenges to the treating physician, as they have comorbidities, lower functional reserves, and higher risk of treatment-related complications. The diagnosis of IBD in the elderly may be difficult due to a more subtle disease presentation and to a wide range of differential diagnosis. Moreover, as these patients are often excluded from clinical trials, there is a lack of high-quality evidence to inform on the most appropriate management. Despite an increasing prevalence, the management of IBD in the elderly is still hindered by frequent misconceptions by physicians treating these patients. Due to a erroneous notion of a milder disease course and fear of adverse events, elderly IBD-patients are managed with frequent and continuous use of steroids and undertreated with effective medical therapies. In this review, we describe the principles of management of IBD in the elderly, which is a topic of increasing importance to IBD clinics, that will have to progressively adapt to care for an ageing population.

Keywords: Crohn's disease; Frailty; Ulcerative colitis.

Publication types

  • Review

MeSH terms

  • Aged
  • Colitis, Ulcerative* / epidemiology
  • Comorbidity
  • Diagnosis, Differential
  • Disease Progression
  • Humans
  • Inflammatory Bowel Diseases* / drug therapy
  • Inflammatory Bowel Diseases* / therapy
  • Steroids / therapeutic use

Substances

  • Steroids